SKLB 1028
SKLB 1028 (Ruserontinib) is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. SKLB 1028 shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.
Product Specifications
CAS Number
1350544-93-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
443.55
Molecular Formula
C24H29N9
Notes
Research use only, not for human use.
Receptor
EGFR | FLT | Bcr-Abl
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
